STJ - St Jude Medical Stock Price, News & Analysis

$80.82 0.13 (0.16 %)
(As of 11/24/2017 04:00 PM ET)
Previous Close$80.69
Today's Range$80.72 - $81.31
52-Week Range$48.83 - $84.00
Volume14.74 million shs
Average Volume8.54 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend Yield1.54%
BetaN/A

About St Jude Medical (NYSE:STJ)

St Jude Medical logoSt. Jude Medical, Inc. is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. The Company's product categories include tachycardia implantable cardioverter defibrillator systems; atrial fibrillation products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems); bradycardia pacemaker systems; vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography imaging products, vascular plugs, heart failure monitoring devices and other vascular accessories); structural heart products (heart valve replacement and repair products and structural heart defect devices); neuromodulation products, and Thoratec products.


Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNYSE:STJ
CUSIP79084910

Debt

Debt-to-Equity Ratio1.20%
Current Ratio1.93%
Quick Ratio1.31%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Dividend

Annual Dividend$1.24
Dividend Yield1.5%

Profitability

Trailing EPS$2.28
Net IncomeN/A
Net Margins14.14%
Return on Equity19.40%
Return on Assets6.75%

Miscellaneous

Employees18,000
Outstanding Shares285,590,000

Frequently Asked Questions for St Jude Medical (NYSE:STJ)

What is St Jude Medical's stock symbol?

St Jude Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "STJ."

How often does St Jude Medical pay dividends? What is the dividend yield for St Jude Medical?

St Jude Medical announced a quarterly dividend on Friday, December 9th. Shareholders of record on Friday, January 13th will be given a dividend of $0.31 per share on Tuesday, January 31st. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.53%. The ex-dividend date is Wednesday, January 11th. View St Jude Medical's Dividend History.

How were St Jude Medical's earnings last quarter?

St Jude Medical Inc (NYSE:STJ) issued its earnings results on Wednesday, July, 20th. The medical technology company reported $1.06 EPS for the quarter, meeting analysts' consensus estimates of $1.06. The medical technology company earned $1.56 billion during the quarter, compared to the consensus estimate of $1.55 billion. St Jude Medical had a return on equity of 19.40% and a net margin of 14.14%. The firm's revenue for the quarter was up 10.8% on a year-over-year basis. During the same period last year, the firm earned $1.07 EPS. View St Jude Medical's Earnings History.

Who are some of St Jude Medical's key competitors?

How do I buy St Jude Medical stock?

Shares of St Jude Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is St Jude Medical's stock price today?

One share of St Jude Medical stock can currently be purchased for approximately $80.82.

How can I contact St Jude Medical?

St Jude Medical's mailing address is 1 Saint Jude Medical Dr, SAINT PAUL, MN 55117-1789, United States. The medical technology company can be reached via phone at +1-651-7562000.


MarketBeat Community Rating for St Jude Medical (STJ)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  538 (Vote Outperform)
Underperform Votes:  547 (Vote Underperform)
Total Votes:  1,085
MarketBeat's community ratings are surveys of what our community members think about St Jude Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for St Jude Medical (NYSE:STJ)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.112.062.192.20
Ratings Breakdown: 0 Sell Ratings
8 Hold Ratings
1 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
15 Hold Ratings
1 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
17 Hold Ratings
4 Buy Ratings
0 Strong Buy Ratings
0 Sell Ratings
20 Hold Ratings
5 Buy Ratings
0 Strong Buy Ratings
Consensus Price Target: $80.43$80.65$76.77$74.71
Price Target Upside: 1.35% upside1.63% upside3.27% downside5.86% downside

Consensus Price Target History for St Jude Medical (NYSE:STJ)

Price Target History for St Jude Medical (NYSE:STJ)

Analysts' Ratings History for St Jude Medical (NYSE:STJ)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/22/2016Barclays PLCReiterated RatingEqual Weight$83.00N/AView Rating Details
10/11/2016Cowen IncReiterated RatingBuy$85.00N/AView Rating Details
9/12/2016Jefferies Group LLCReiterated RatingHold$60.00N/AView Rating Details
8/28/2016ArgusReiterated RatingHoldN/AView Rating Details
8/28/2016Credit Suisse GroupReiterated RatingNeutral$81.00N/AView Rating Details
7/20/2016Canaccord GenuitySet Price TargetHold$85.00N/AView Rating Details
7/21/2016Leerink SwannReiterated RatingHold$85.00N/AView Rating Details
7/17/2016J P Morgan Chase & CoReiterated RatingHoldN/AView Rating Details
7/15/2016WedbushDowngradeOutperform -> Neutral$70.00 -> $84.00N/AView Rating Details
5/10/2016SunTrust Banks, Inc.DowngradeBuy -> Neutral$70.00 -> $80.00N/AView Rating Details
5/2/2016Morgan StanleyDowngradeOverweight -> Equal Weight$67.00 -> $81.00N/AView Rating Details
4/30/2016Wells Fargo & CompanyReiterated RatingHoldN/AView Rating Details
4/29/2016William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
4/29/2016Needham & Company LLCDowngradeBuy -> HoldN/AView Rating Details
4/28/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
4/18/2016BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
4/15/2016Bank of America CorporationReiterated RatingBuy$66.00N/AView Rating Details
3/28/2016Oppenheimer Holdings, Inc.Boost Price TargetMarket Perform$57.00 -> $67.00N/AView Rating Details
3/28/2016BMO Capital MarketsBoost Price TargetOutperform$66.00 -> $73.00N/AView Rating Details
3/16/2016NomuraInitiated CoverageBuy$64.00N/AView Rating Details
1/25/2016Royal Bank Of CanadaLower Price TargetSector Perform$66.00 -> $57.00N/AView Rating Details
1/15/2016Deutsche Bank AGLower Price TargetHold$65.00 -> $64.00N/AView Rating Details
1/4/2016Sterne Agee CRTLower Price TargetBuy$81.00 -> $78.00N/AView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History and Estimates Chart for St Jude Medical (NYSE:STJ)

Earnings by Quarter for St Jude Medical (NYSE:STJ)

Earnings History by Quarter for St Jude Medical (NYSE STJ)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/19/2016Q316$1.01$0.99$1.50 billion$1.50 billionViewListenView Earnings Details
7/20/2016Q216$1.06$1.06$1.55 billion$1.56 billionViewListenView Earnings Details
4/20/2016Q116$0.88$0.90$1.43 billion$1.45 billionViewListenView Earnings Details
1/27/2016Q415$1.01$1.02$1.48 billion$1.45 billionViewListenView Earnings Details
10/21/2015Q315$0.97$0.97$1.35 billion$1.34 billionViewListenView Earnings Details
7/22/2015Q215$1.00$1.03$1.39 billion$1.41 billionViewListenView Earnings Details
4/22/2015Q115$0.91$0.93$1.32 billion$1.35 billionViewN/AView Earnings Details
1/28/2015Q414$1.03$1.03$1.44 billion$1.44 billionViewN/AView Earnings Details
10/15/2014Q314$0.96$0.97$1.39 billion$1.38 billionViewListenView Earnings Details
7/16/2014Q214$1.00$1.02$1.44 billion$1.45 billionViewN/AView Earnings Details
4/16/2014Q114$0.95$0.96$1.36 million$1.36 millionViewN/AView Earnings Details
1/22/2014Q413$0.97$0.99$1.38 billion$1.42 billionViewListenView Earnings Details
10/16/2013Q313$0.89$0.90$1.32 billion$1.34 billionViewListenView Earnings Details
7/17/2013Q2 2013$0.94$0.96$1.36 billion$1.40 billionViewListenView Earnings Details
4/17/2013Q1 2013$0.91$0.92$1.36 billion$1.34 billionViewListenView Earnings Details
1/23/2013Q4 2012$0.87$0.92$1.37 billion$1.37 billionViewListenView Earnings Details
10/17/2012$0.81$0.83ViewN/AView Earnings Details
7/18/2012$0.87$0.86ViewN/AView Earnings Details
4/18/2012$0.83$0.86ViewN/AView Earnings Details
1/25/2012$0.84$0.86ViewN/AView Earnings Details
10/19/2011$0.76$0.78ViewN/AView Earnings Details
7/20/2011$0.84$0.85ViewN/AView Earnings Details
4/20/2011$0.78$0.80ViewN/AView Earnings Details
1/26/2011$0.74$0.75ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for St Jude Medical (NYSE:STJ)
2017 EPS Consensus Estimate: $4.43
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$0.98$1.02$1.00
Q2 20175$1.12$1.17$1.14
Q3 20176$1.08$1.16$1.12
Q4 20175$1.14$1.26$1.18
Q1 20182$1.07$1.09$1.08
Q2 20182$1.22$1.30$1.26
Q3 20182$1.17$1.23$1.20
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for St Jude Medical (NYSE:STJ)

Most Recent Dividend:1/31/2017
Annual Dividend:$1.24
Dividend Yield:1.53%
Dividend Growth:7.60% (3 Year Average)
Payout Ratio:54.39% (Trailing 12 Months of Earnings)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for St Jude Medical (NYSE:STJ)

Dividend History by Quarter for St Jude Medical (NYSE STJ)

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/9/2016quarterly$0.311.55%1/11/20171/13/20171/31/2017
8/3/2016quarterly$0.311.49%9/28/20169/30/201610/28/2016
5/4/2016quarterly$0.311.64%6/28/20166/30/20167/29/2016
2/19/2016quarterly$0.312.3%3/29/20163/31/20164/29/2016
12/7/2015quarterly$0.291.9%12/29/201512/31/20151/29/2016
8/4/2015quarterly$0.291.58%9/28/20159/30/201510/30/2015
5/6/2015quarterly$0.291.63%6/26/20156/30/20157/31/2015
2/20/2015quarterly$0.291.69%3/27/20153/31/20154/30/2015
10/21/2014quarterly$0.271.81%12/29/201412/31/20141/30/2015
7/29/2014quarterly$0.271.62%9/26/20149/30/201410/31/2014
5/1/2014quarterly$0.271.71%6/26/20146/30/20147/31/2014
2/24/2014quarterly$0.271.6%3/27/20143/31/20144/30/2014
12/9/2013quarterly$0.251.68%12/27/201312/31/20131/31/2014
7/30/2013quarterly$0.251.91%9/26/20139/30/201310/31/2013
5/1/2013quarterly$0.252.46%6/26/20136/28/20137/31/2013
2/25/2013quarterly$0.252.45%3/26/20133/29/20134/30/2013
12/11/2012quarterly$0.232.59%12/27/201212/31/20121/31/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for St Jude Medical (NYSE STJ)

Insider Ownership Percentage: 4.80%
Institutional Ownership Percentage: 82.73%
Insider Trades by Quarter for St Jude Medical (NYSE:STJ)
Institutional Ownership by Quarter for St Jude Medical (NYSE:STJ)

Insider Trades by Quarter for St Jude Medical (NYSE STJ)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/5/2016Jeff FechoVPSell10,408$51.71$538,197.68View SEC Filing  
12/21/2015Donald ZurbayCFOSell3,106$60.96$189,341.76View SEC Filing  
12/21/2015Jeff DallagerVPSell501$60.94$30,530.94View SEC Filing  
12/18/2015John C HeinmillerEVPSell8,009$61.16$489,830.44View SEC Filing  
10/28/2015Daniel J. StarksCEOSell120,000$62.36$7,483,200.00View SEC Filing  
4/28/2015Daniel J StarksCEOSell100,000$72.46$7,246,000.00View SEC Filing  
4/27/2015Mark W MurphyVPSell5,882$72.45$426,150.90View SEC Filing  
4/24/2015Jason ZellersVPSell3,566$74.13$264,347.58View SEC Filing  
4/24/2015Joel BeckerInsiderSell17,870$73.87$1,320,056.90View SEC Filing  
4/24/2015John C HeinmillerEVPSell160,000$73.69$11,790,400.00View SEC Filing  
4/24/2015Lisa AndradeCMOSell5,000$73.87$369,350.00View SEC Filing  
4/24/2015Stuart EssigDirectorSell7,750$73.85$572,337.50View SEC Filing  
4/22/2015I Paul BaeVPSell34,000$73.00$2,482,000.00View SEC Filing  
4/22/2015Lisa AndradeCMOSell5,000$70.55$352,750.00View SEC Filing  
2/10/2015Michael A RoccaDirectorSell3,875$65.57$254,083.75View SEC Filing  
2/6/2015Michael T RousseauCOOSell7,207$67.31$485,103.17View SEC Filing  
2/3/2015Denis M GestinInsiderSell148,500$67.13$9,968,805.00View SEC Filing  
2/3/2015Scott ThomeVPSell6,666$67.94$452,888.04View SEC Filing  
2/2/2015Mark W MurphyVPSell859$66.92$57,484.28View SEC Filing  
2/2/2015Richard R DevenutiDirectorSell7,750$66.43$514,832.50View SEC Filing  
12/18/2014John C HeinmillerEVPSell6,853$64.60$442,703.80View SEC Filing  
10/27/2014Jeff FechoVPSell500$60.55$30,275.00View SEC Filing  
10/23/2014Jason ZellersVPSell33,999$60.04$2,041,299.96View SEC Filing  
10/22/2014Daniel J StarksCEOSell100,000$60.04$6,004,000.00View SEC Filing  
7/30/2014Mark CarlsonVPSell1,198$66.40$79,547.20View SEC Filing  
7/29/2014Daniel J StarksCEOSell90,000$66.25$5,962,500.00View SEC Filing  
7/29/2014Mark W MurphyVPSell2,000$66.43$132,860.00View SEC Filing  
7/28/2014Denis M GestinInsiderSell99,000$66.76$6,609,240.00View SEC Filing  
7/28/2014Rachel EllingsonVPSell2,630$66.72$175,473.60View SEC Filing  
7/18/2014Scott ThomeVPSell5,997$67.06$402,158.82View SEC Filing  
2/6/2014Michael RoccaDirectorSell5,600$60.36$338,016.00View SEC Filing  
2/5/2014Scott ThomeVPSell7,500$59.57$446,775.00View SEC Filing  
2/4/2014Michael RousseauCOOSell4,644$59.76$277,525.44View SEC Filing  
1/27/2014Jeff FechoVPSell10,408$61.28$637,802.24View SEC Filing  
1/27/2014Joel BeckerInsiderSell14,164$61.58$872,219.12View SEC Filing  
1/24/2014Mark MurphyVPSell9,480$63.14$598,567.20View SEC Filing  
12/18/2013Joel BeckerInsiderSell37,916$59.54$2,257,518.64View SEC Filing  
12/18/2013John HeinmillerEVPSell4,144$59.49$246,526.56View SEC Filing  
12/16/2013Frank CallaghanInsiderSell73,826$59.28$4,376,405.28View SEC Filing  
12/9/2013Daniel StarksCEOSell108,000$59.41$6,416,280.00View SEC Filing  
11/5/2013Daniel StarksCEOSell108,000$57.33$6,191,640.00View SEC Filing  
10/31/2013Michael T RousseauInsiderSell50,000$57.81$2,890,500.00View SEC Filing  
10/29/2013Kathy ChesterVPSell9,375$58.12$544,875.00View SEC Filing  
10/29/2013Michael T RousseauInsiderSell50,000$57.76$2,888,000.00View SEC Filing  
10/28/2013Donald ZurbayCFOSell40,000$57.31$2,292,400.00View SEC Filing  
10/28/2013Mark W MurphyVPSell5,024$57.51$288,930.24View SEC Filing  
10/25/2013Jason ZellersVPSell14,917$57.15$852,506.55View SEC Filing  
10/24/2013Joel BeckerInsiderSell9,613$56.48$542,942.24View SEC Filing  
10/23/2013John C HeinmillerEVPSell150,000$56.48$8,472,000.00View SEC Filing  
10/23/2013Kathy ChesterVPSell20,000$56.50$1,130,000.00View SEC Filing  
10/22/2013Angela D CraigVPSell24,402$56.59$1,380,909.18View SEC Filing  
10/21/2013Frank J CallaghanInsiderSell133,096$56.26$7,487,980.96View SEC Filing  
10/21/2013Mark W MurphyVPSell3,930$56.26$221,101.80View SEC Filing  
10/18/2013Jason ZellersVPSell10,916$56.56$617,408.96View SEC Filing  
10/18/2013Michael T RousseauInsiderSell61,000$56.65$3,455,650.00View SEC Filing  
10/18/2013Wendy L YarnoDirectorSell22,150$56.50$1,251,475.00View SEC Filing  
10/4/2013Denis GestinInsiderSell137,000$55.25$7,569,250.00View SEC Filing  
10/4/2013Donald ZurbayCFOSell12,000$55.55$666,600.00View SEC Filing  
9/11/2013Mark MurphyVPSell4,200$53.50$224,700.00View SEC Filing  
8/9/2013Angela CraigVPSell13,600$54.00$734,400.00View SEC Filing  
8/9/2013Frank CallaghanInsiderSell11,000$54.00$594,000.00View SEC Filing  
7/29/2013Jason ZellersVPSell10,359$52.22$540,946.98View SEC Filing  
7/29/2013Stuart EssigDirectorSell5,600$52.19$292,264.00View SEC Filing  
7/25/2013Kathy ChesterVPSell16,250$52.00$845,000.00View SEC Filing  
7/22/2013Jason ZellersVPSell7,341$51.91$381,071.31View SEC Filing  
7/19/2013Donald ZurbayCFOSell50,000$51.28$2,564,000.00View SEC Filing  
7/19/2013Jeff FechoVPSell13,848$50.82$703,755.36View SEC Filing  
7/19/2013Joel BeckerInsiderSell11,700$50.50$590,850.00View SEC Filing  
5/2/2013Richard R DevenutiDirectorSell5,270$40.64$214,172.80View SEC Filing  
2/5/2013Denis M GestinInsiderSell90,000$41.32$3,718,800.00View SEC Filing  
2/5/2013Thomas R NorthenscoldVPSell22,000$41.40$910,800.00View SEC Filing  
10/25/2012John W BrownDirectorBuy25,000$38.65$966,250.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for St Jude Medical (NYSE STJ)

Source:
DateHeadline
Reviewing St Jude Medical (STJ) and Its CompetitorsReviewing St Jude Medical (STJ) and Its Competitors
www.americanbankingnews.com - November 22 at 7:47 AM
Analyzing St Jude Medical (STJ) and Its RivalsAnalyzing St Jude Medical (STJ) and Its Rivals
www.americanbankingnews.com - November 21 at 5:24 PM
Contrasting St Jude Medical (STJ) & Its CompetitorsContrasting St Jude Medical (STJ) & Its Competitors
www.americanbankingnews.com - November 21 at 3:16 PM
Reviewing St Jude Medical (STJ) & The CompetitionReviewing St Jude Medical (STJ) & The Competition
www.americanbankingnews.com - November 21 at 11:20 AM
St Jude Medical (STJ) versus Its Peers Head to Head SurveySt Jude Medical (STJ) versus Its Peers Head to Head Survey
www.americanbankingnews.com - November 21 at 1:22 AM
Reviewing St Jude Medical (STJ) & Its CompetitorsReviewing St Jude Medical (STJ) & Its Competitors
www.americanbankingnews.com - November 19 at 7:14 PM
St Jude Medical (STJ) versus Its Competitors Critical AnalysisSt Jude Medical (STJ) versus Its Competitors Critical Analysis
www.americanbankingnews.com - November 19 at 5:06 PM
Comparing St Jude Medical (STJ) and Its PeersComparing St Jude Medical (STJ) and Its Peers
www.americanbankingnews.com - November 16 at 3:36 PM
Uroplasty (UPI) & St Jude Medical (STJ) Head to Head ContrastUroplasty (UPI) & St Jude Medical (STJ) Head to Head Contrast
www.americanbankingnews.com - November 15 at 11:24 PM
Abbott beats Street on strong medical device, generics salesAbbott beats Street on strong medical device, generics sales
www.reuters.com - October 19 at 9:22 AM
RPRD Diagnostics Partners With St. Jude Childrens Research Hospital To Offer Comprehensive Pharmacogenetics TestingRPRD Diagnostics Partners With St. Jude Children's Research Hospital To Offer Comprehensive Pharmacogenetics Testing
www.thestreet.com - October 19 at 9:22 AM
Abbott tops profit estimates on strong medical device salesAbbott tops profit estimates on strong medical device sales
www.reuters.com - October 18 at 9:00 AM
Global Pain Management Drugs & Devices Industry Forecasts (2017-2021) by Market Size (Volume and Value), Sales Price, &Gross MarginGlobal Pain Management Drugs & Devices Industry Forecasts (2017-2021) by Market Size (Volume and Value), Sales Price, &Gross Margin
www.marketwatch.com - October 14 at 8:15 AM
Global Pain Management Drugs & Devices Industry Forecast to 2021 with Sales, Sales Price and Gross Margin AnalysisGlobal Pain Management Drugs & Devices Industry Forecast to 2021 with Sales, Sales Price and Gross Margin Analysis
www.marketwatch.com - October 12 at 8:40 PM
The Melting Pot Announces 14th Year of Partnership with St. Jude Childrens Research Hospital Thanks and Giving® CampaignThe Melting Pot Announces 14th Year of Partnership with St. Jude Children's Research Hospital Thanks and Giving® Campaign
www.prnewswire.com - October 11 at 8:09 AM
Head to Head Comparison: St Jude Medical (STJ) vs. Trivascular Technologies (TRIV)Head to Head Comparison: St Jude Medical (STJ) vs. Trivascular Technologies (TRIV)
www.americanbankingnews.com - October 7 at 12:18 AM
Mairs and Power Finds Value and Growth Close to HomeMairs and Power Finds Value and Growth Close to Home
finance.yahoo.com - October 6 at 10:46 AM
DiCello Levitt & Casey and Tousley Brain Stephens File Class Action Lawsuit Over Recalled Implantable Cardiac DefibrillatorsDiCello Levitt & Casey and Tousley Brain Stephens File Class Action Lawsuit Over Recalled Implantable Cardiac Defibrillators
www.businesswire.com - September 20 at 9:32 AM
Head to Head Review: RTI Surgical (RTIX) & St Jude Medical (STJ)Head to Head Review: RTI Surgical (RTIX) & St Jude Medical (STJ)
www.americanbankingnews.com - September 10 at 4:08 PM
UPDATE 1-Abbott releases new round of cyber updates for St. Jude pacemakersUPDATE 1-Abbott releases new round of cyber updates for St. Jude pacemakers
www.businessinsider.com - August 31 at 10:35 AM
St. Jude unveils powerful resource to advance treatment of pediatric solid tumorsSt. Jude unveils powerful resource to advance treatment of pediatric solid tumors
www.bizjournals.com - August 31 at 10:34 AM
Abbott issues second round of updates on St. Jude pacersAbbott issues second round of updates on St. Jude pacers
seekingalpha.com - August 30 at 9:41 AM
Stryker Corporation (SYK) and St Jude Medical (STJ) Financial ReviewStryker Corporation (SYK) and St Jude Medical (STJ) Financial Review
www.americanbankingnews.com - August 28 at 2:24 PM
2017 Health Care Heroes Lifetime Achievement: Dr. Larry Kun with St. Jude2017 Health Care Heroes Lifetime Achievement: Dr. Larry Kun with St. Jude
www.bizjournals.com - August 18 at 7:32 AM
BRIEF-IMF Bentham says Canadian unit proposes to fund class action against St. Jude Medical, IncBRIEF-IMF Bentham says Canadian unit proposes to fund class action against St. Jude Medical, Inc
www.reuters.com - August 14 at 6:01 AM
St Jude Medical (STJ) vs. Uroplasty (UPI) Head to Head ComparisonSt Jude Medical (STJ) vs. Uroplasty (UPI) Head to Head Comparison
www.americanbankingnews.com - August 9 at 12:24 PM
Analyzing St Jude Medical (STJ) and Endologix (ELGX)Analyzing St Jude Medical (STJ) and Endologix (ELGX)
www.americanbankingnews.com - August 2 at 12:16 AM
St. Jude Childrens Research Hospital®, ALSAC Announce Chairs of Boards of Directors and GovernorsSt. Jude Children's Research Hospital®, ALSAC Announce Chairs of Boards of Directors and Governors
www.bizjournals.com - July 25 at 7:05 AM
Abbott Labs sales increase as St. Jude devices reboundAbbott Labs sales increase as St. Jude devices rebound
www.bizjournals.com - July 22 at 9:12 AM
St. Jude-led researchers identify flu-risk genetic markerSt. Jude-led researchers identify flu-risk genetic marker
www.bizjournals.com - July 18 at 8:34 AM
Toys"R"Us® Helps Raise Nearly $3 Million For St. Jude Childrens Research Hospital®Toys"R"Us® Helps Raise Nearly $3 Million For St. Jude Children's Research Hospital®
www.prnewswire.com - July 13 at 9:57 AM
Healthcare Uncertainty No Match For Abbott CFOHealthcare Uncertainty No Match For Abbott CFO
www.forbes.com - July 11 at 3:51 PM
RenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive OfficerRenalGuard Solutions Appoints Jim Dillon, Former St. Jude Medical and Abiomed Executive, as Chief Executive Officer
feeds.benzinga.com - July 10 at 8:49 AM
St. Jude MedicalSt. Jude Medical
fortune.com - June 7 at 10:25 AM
St. Jude-led study shows good news for childhood cancer survivorsSt. Jude-led study shows good news for childhood cancer survivors
www.bizjournals.com - June 5 at 10:13 PM
County talks about pulling funding from Uptown, St. Jude effortsCounty talks about pulling funding from Uptown, St. Jude efforts
www.bizjournals.com - May 3 at 6:13 PM
UPDATE 1-Abbott sales, profit propped up by St. Jude acquisitionUPDATE 1-Abbott sales, profit propped up by St. Jude acquisition
www.businessinsider.com - April 20 at 1:01 AM
Recalled St. Jude devices were used in patients: FDARecalled St. Jude devices were used in patients: FDA
www.bizjournals.com - April 17 at 8:51 AM
St. Jude Medical Played Down Defibrillator Failures for Years, F.D.A. SaysSt. Jude Medical Played Down Defibrillator Failures for Years, F.D.A. Says
www.nytimes.com - April 14 at 12:24 PM
Benihana Supports St. Jude Childrens Research Hospital® with 9th Annual Childrens Day InitiativeBenihana Supports St. Jude Children's Research Hospital® with 9th Annual Children's Day Initiative
www.bizjournals.com - April 3 at 7:47 PM
Can Abbott Outperform Despite Alere? - TheStreet - TheStreet.comCan Abbott Outperform Despite Alere? - TheStreet - TheStreet.com
www.thestreet.com - March 24 at 7:56 PM
St. Jude Medical, Inc. -- Moodys withdraws St. Jude Medicals note ratingsSt. Jude Medical, Inc. -- Moody's withdraws St. Jude Medical's note ratings
www.moodys.com - March 24 at 7:56 PM
Former St. Jude Medical V.P. admits swindling from companyFormer St. Jude Medical V.P. admits swindling from company
www.bizjournals.com - March 9 at 7:58 PM
Fitch Rates Abbotts Notes Offering BBB; Outlook StableFitch Rates Abbott's Notes Offering 'BBB'; Outlook Stable
www.reuters.com - February 28 at 7:39 PM
BRIEF-FTC approves final order settling charges for Abbotts deal with St. Jude MedicalBRIEF-FTC approves final order settling charges for Abbott's deal with St. Jude Medical
www.reuters.com - February 23 at 8:15 PM
St. Jude Childrens Research Hospital® Thanks And Giving Raises $107 Million For The Research And Treatment Of Childhood CancerSt. Jude Children's Research Hospital® Thanks And Giving Raises $107 Million For The Research And Treatment Of Childhood Cancer
www.streetinsider.com - February 23 at 8:15 PM
Abbott Laboratories -- Moodys assigns Baa3 to Abbotts proposed exchange notesAbbott Laboratories -- Moody's assigns Baa3 to Abbott's proposed exchange notes
www.moodys.com - February 23 at 8:15 PM
Abbott launches exchange offer for $3.1B in St. Jude debtAbbott launches exchange offer for $3.1B in St. Jude debt
seekingalpha.com - February 21 at 4:54 PM
Form 425 ST JUDE MEDICAL, LLC Filed by: ABBOTT LABORATORIESForm 425 ST JUDE MEDICAL, LLC Filed by: ABBOTT LABORATORIES
www.streetinsider.com - February 21 at 4:54 PM
Ubs Oconnor Llc Buys St Jude Medical, Gulfport Energy, Molson Coors Brewing Co, Sells Ingram ...Ubs Oconnor Llc Buys St Jude Medical, Gulfport Energy, Molson Coors Brewing Co, Sells Ingram ...
www.nasdaq.com - February 18 at 8:53 AM

Social Media

Financials

Chart

St Jude Medical (NYSE STJ) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.